Vaccines

A person in Texas tested positive for highly pathogenic avian influenza after having exposure to dairy cattle that are presumed to also be infected with the virus, health officials reported.

Artificial intelligence has emerged as a potentially important tool for patient care, including in infectious diseases.

Zika virus is an important mosquito-borne pathogen with significant public health concerns. Zika vaccine development is an ongoing area of research with several candidates in the pipeline.

The latest COVID-19 vaccines reduce the risk for hospitalization or visits to an ED or urgent care by around 50%, according to interim data published in MMWR.

In a new clinical report, the AAP provides strategies to help pediatricians and other health care providers address parental vaccine concerns and increase immunization rates.

COVAX, the multinational program launched in 2020 to deliver COVID-19 vaccines to low- and lower-middle income countries, will end on Dec. 31, 2023, as the vaccines shift to routine immunization programs.

To break the cycle of recurrent Clostridioides difficile infection, physicians have shifted treatment strategies from antibiotics to fecal microbiota transplantation and live biotherapeutic products.

Innovation in asthma and allergy care continued in 2023. Healio’s most popular stories this year covered breakthroughs in immunotherapy treatments for food allergy and revised looks at common treatments for congestion and allergy.

Major vaccine developments in 2023 included the approvals of the first two vaccines against respiratory syncytial virus, the first chikungunya vaccine, a new vaccine against malaria, and a move to new monovalent COVID-19 vaccines.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.